Project Information



BD celebrates opening of new manufacturing facility in Tatabánya, Hungary


Contact:
Vikki Lomas
BD Corporate Communications
+44 7827 894871

Tatabánya, Hungary (8 April 2010) – BD (Becton, Dickinson and Company), a leading global medical technology company, today celebrated the grand opening of its new production facility in Tatabánya, Hungary.  Construction of this new €100 million, state-of-the-art facility began in 2008, and production is expected to start in 2010.  BD is expected to employ approximately 500 people at the facility by 2014.

Completion of this new manufacturing facility marks an important milestone for BD and reinforces the Company’s commitment to making the highest quality products available to customers.  It will also help meet the growing worldwide demand for the prefillable syringes that are sold to pharmaceutical and biotechnology firms whose injectable drugs are delivered using these devices.  BD pioneered the production of prefillable injection devices and continues to be a global leader in the field. 

“BD chose to establish this important production facility in Hungary because of the proximity to the important European customers it will serve,” said Claude Dartiguelongue, President, BD Medical – Pharmaceutical Systems. “The availability of a highly skilled workforce, access to qualified subcontractors, and the support of local public officials were also key factors in our selection of this attractive location for BD's new manufacturing presence."

The building design incorporates features intended to reduce energy and water consumption, reflecting BD’s commitment to environmental stewardship.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.  For more information, please visit www.bd.com.

***